128 related articles for article (PubMed ID: 10654163)
1. Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency.
Joussen AM; Germann T; Kirchhof B
Graefes Arch Clin Exp Ophthalmol; 1999 Dec; 237(12):952-61. PubMed ID: 10654163
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor.
Kruse FE; Joussen AM; Rohrschneider K; Becker MD; Völcker HE
Graefes Arch Clin Exp Ophthalmol; 1998 Jun; 236(6):461-6. PubMed ID: 9646092
[TBL] [Abstract][Full Text] [Related]
3. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization.
Kenyon BM; Browne F; D'Amato RJ
Exp Eye Res; 1997 Jun; 64(6):971-8. PubMed ID: 9301478
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits.
Lee YK; Chung SK
Cornea; 2013 Aug; 32(8):1142-8. PubMed ID: 23739149
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of corneal angiogenesis by local application of vasostatin.
Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo.
Lu Y; Zheng Y; Ai J; Xu X
Discov Med; 2016 May; 21(117):349-61. PubMed ID: 27355331
[TBL] [Abstract][Full Text] [Related]
7. Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor.
Loughman MS; Chatzistefanou K; Gonzalez EM; Flynn E; Adamis AP; Shing Y; D'Amato RJ; Folkman J
Aust N Z J Ophthalmol; 1996 Aug; 24(3):289-95. PubMed ID: 8913136
[TBL] [Abstract][Full Text] [Related]
8. A model of angiogenesis in the mouse cornea.
Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage.
Wang B; Li PK; Ma JX; Chen D
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3630-3642. PubMed ID: 30029250
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide prevents donor corneal graft neovascularization in an alkali burn model of corneal angiogenesis.
Abbas A; Khan B; Feroze AH; Hyman GF
J Pak Med Assoc; 2002 Oct; 52(10):476-82. PubMed ID: 12553678
[TBL] [Abstract][Full Text] [Related]
11. Suppression of corneal neovascularization by culture supernatant of human amniotic cells.
Kobayashi N; Kabuyama Y; Sasaki S; Kato K; Homma Y
Cornea; 2002 Jan; 21(1):62-7. PubMed ID: 11805510
[TBL] [Abstract][Full Text] [Related]
12. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic therapy in multiple myeloma.
Tosi P; Tura S
Acta Haematol; 2001; 106(4):208-13. PubMed ID: 11815718
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of corneal neovascularization by rapamycin.
Kwon YS; Kim JC
Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
[TBL] [Abstract][Full Text] [Related]
15. Studying Angiogenesis in the Rabbit Corneal Pocket Assay.
Morbidelli L; Ciccone V; Ziche M
Methods Mol Biol; 2021; 2206():89-101. PubMed ID: 32754813
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of experimental angiogenesis of cornea by somatostatin.
Wu PC; Liu CC; Chen CH; Kou HK; Shen SC; Lu CY; Chou WY; Sung MT; Yang LC
Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):63-9. PubMed ID: 12545294
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits.
Koh CH; Lee HS; Chung SK
Cornea; 2014 May; 33(5):527-32. PubMed ID: 24608256
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice.
Kotoh T; Dhar DK; Masunaga R; Tabara H; Tachibana M; Kubota H; Kohno H; Nagasue N
Surgery; 1999 May; 125(5):536-44. PubMed ID: 10330943
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma.
Myoung H; Hong SD; Kim YY; Hong SP; Kim MJ
Cancer Lett; 2001 Feb; 163(2):191-200. PubMed ID: 11165754
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide is an inhibitor of angiogenesis.
D'Amato RJ; Loughnan MS; Flynn E; Folkman J
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4082-5. PubMed ID: 7513432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
